The association of claudin-18 and androgen receptor expression in prostatic carcinoma: an immunohistochemical study

The association of claudin-18 and androgen receptor expression in prostatic carcinoma: an immunohistochemical study

Abstract Background Claudin-18 (CLDN18) is a recently identified anticancer therapeutic target with promising results for various gastrointestinal malignancies. The role of CLDN18 in prostatic carcinoma has not been investigated. The aim of this study was to investigate CLDN18 and androgen receptor...

Full description

Bibliographic Details
Main Authors: Heba M. Rashad, Hanan Ahmed, Kareem Ali El Attar, Eman A. Saad
Format: Article
Language:English
Published: SpringerOpen 2023-11-01
Series:Beni-Suef University Journal of Basic and Applied Sciences
Subjects:
CLDN18
AR
Prostatic carcinoma
Online Access:https://doi.org/10.1186/s43088-023-00449-7

Similar Items

Similar Items